Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: BMC Cancer 18 (2018).
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2018
- Creator
-
Alunni-Fabbroni, Marianna
Majunke, Leonie
Trapp, Elisabeth K.
Tzschaschel, Marie
Mahner, Sven
Fasching, Peter A.
Fehm, Tanja
Schneeweiss, Andreas
Beck, Thomas
Lorenz, Ralf
Friedl, Thomas W. P.
Janni, Wolfgang
Rack, Brigitte
- URN
-
urn:nbn:de:bvb:29-opus4-96962
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alunni-Fabbroni, Marianna
- Majunke, Leonie
- Trapp, Elisabeth K.
- Tzschaschel, Marie
- Mahner, Sven
- Fasching, Peter A.
- Fehm, Tanja
- Schneeweiss, Andreas
- Beck, Thomas
- Lorenz, Ralf
- Friedl, Thomas W. P.
- Janni, Wolfgang
- Rack, Brigitte
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2018
Other Objects (12)
Repositionierung von Disulfiram zur Therapie des Ovarialkarzinoms
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
AGO Algorithms for the Treatment of Breast Cancer: Update 2021
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients
Circulating MicroRNAs as Biomarkers for Sepsis
Repositionierung von Disulfiram zur Therapie des Ovarialkarzinoms
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
AGO Algorithms for the Treatment of Breast Cancer: Update 2021
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients
Circulating MicroRNAs as Biomarkers for Sepsis
Repositionierung von Disulfiram zur Therapie des Ovarialkarzinoms
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
AGO Algorithms for the Treatment of Breast Cancer: Update 2021
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients